According to GuruFocus Insider Data, these are the largest CEO sales during the past week. The overall trend of CEOs is illustrated in the chart below:
During its 2016 fiscal year, Best Buy (BBY, Financial) continued to grow its Domestic segment revenue and its operating margin. The company increased its domestic segment online revenue by 13% to over $4 billion. For its 2017 fiscal year, Best Buy plans to improve existing business, decrease expenses and costs and take vital action to drive future business. The company expects these steps to create noticeable results starting in the 2018 fiscal year.
GuruFocus has found three severe warning signs for Best Buy:
- Declining revenue per share.
- Declining gross margin.
- Declining operating margin.
Best Buy announced its 2017 first fiscal quarter results. The company reported revenues of $8.4 billion and net income of $229 million. This compares to its 2016 first quarter revenues of $8.6 billion and net income of $129 million. Best Buy also declared comparable sales growth, which declined from 2.2% in 2012 to 1.0% in 2014. However, comparable sales for the 2016 fiscal year are at 0.5%.
Recent trades
Chairman and CEO Hubert Joly sold 398,000 shares of Best Buy stock on June 2 at the price of $32.24. Chief Admin. Officer and CFO Sharon Mccollam sold 511,897 shares of Best Buy stock on March 9 at the price of $34.15. VP, Finance - Contr. and CAO Mathew Watson and Pres, U.S. Retail & CHRO Shari L. Ballard together sold 188,052 shares of Best Buy stock in February, March and May.
Iron Mountain: President and CEO William L. Meaney sold 315,178 shares
President and CEO of Iron Mountain Inc. (IRM, Financial) William L. Meaney sold 315,178 shares on March 31 at a price of $36.54. Iron Mountain has a market cap of $7.75 billion; its shares were traded around $36.52 with a P/E ratio of 52.92 and P/S ratio of 2.59. The trailing 12-month dividend yield of Iron Mountain stocks is 5.29%. The forward dividend yield of Iron Mountain stocks is 5.28%. Iron Mountain had an annual average earnings growth of 3.00% over the past 10 years.
Iron Mountain stock prices have ranged from $20 to $40 per shares for the past 10 years. Also, since 2009, Iron Mountain revenues have remained relatively constant at around $3.0 billion.
Iron Mountain strives to grow its revenue through multiple means such as better sales and marketing efforts in developed markets like the U.S., Canada, Australia and Western Europe and improved leadership positions in emerging markets like in Eastern Europe, Latin America and the Asia Pacific region. In addition, the company hopes to engage in “adjacent business opportunities” for long-term growth. Iron Mountain also plans to increase its amount of storage rental globally in order to increase its presence in existing and developing markets.
GuruFocus has found two severe warning for Iron Mountain:
- Declining revenue per share.
- Long-term debt.
Iron Mountain released its 2016 first fiscal quarter results with revenues of $750.7 million and net earnings of $63.0 million compared with the 2015 first fiscal quarter revenues of $749.3 and net earnings of $41.7 million.
Recent trades
Sr. VP and Chief Strategy Officer Edward Bicks, EVP, Gen. Counsel, Secretary Ernest W. Cloutier, President Iron Mountain Int'l. Marc A. Duale, Sr. VP and GM, Data Management Eileen Sweeney and Director Clark H. Bailey together sold 120,709 shares of Iron Mountain stock in February, April, May and June.
AbbVie: Chairman of the Board and CEO Richard A. Gonzalez sold 285,953 shares
Chairman of the Board and CEO of AbbVie Inc. (ABBV, Financial) Richard A. Gonzalez sold 285,953 shares on June 2 at a price of $63.82. AbbVie has a market cap of $97.16 billion; its shares were traded around $62.05 with a P/E ratio of 18.68 and P/S ratio of 4.29. The trailing 12-month dividend yield of AbbVie stocks is 3.48%. The forward dividend yield of AbbVie stocks is 3.51%. AbbVie had an annual average earnings growth of 0.80% over the past five years.
AbbVie stock prices have steadily increased since the end of 2012. This growth is mainly driven by increasing revenues because of the continual global popularity of HUMIRA, a drug that can treat arthritis, plaque psoriasis, etc., as well as products such as Creon and Duodopa.
AbbVie is focused on declaring strong financial results, advancing and investing in its pipeline and returning value to shareholders by ensuring a long-term, growing business. In 2015, the company grew its net revenues by 15% to 22.9 billion and had diluted earnings of $3.13 per share.
GuruFocus has found one severe warning sign for Abbvie:
- Faster asset growth than revenue growth.
This may indicate that the company is becoming less efficient.
AbbVie released its 2016 first-quarter results with net revenues of $6.0 billion and net earnings of $1.4 billion. This is compared with the company’s 2015 first-quarter results with net revenues of $5.0 billion and net earnings of $1.02 million.
Recent trades
Chairman of the Board and CEO Richard A Gonzalez sold 324,953 shares of ABBV stock altogether in May and June. VP, Controller Thomas A. Hurwich, SVP, Human Resources Timothy J. Richmond, EVP, Commercial Operations Carlos Alban, Executive Vice President Laura J Schumacher, and SVP, Human Resources Timothy J. Richmond sold 112,887 shares of Abbvie stock in March and May.
Builders FirstSource: CEO Floyd F. Sherman sold 270,000 shares
Builders FirstSource Inc. (BLDR, Financial) CEO Floyd F Sherman sold 270,000 shares on June 1 at a price of $12.01. Builders Firstsource has a market cap of $1.29 billion; its shares were traded around $11.85 with and P/S ratio of 0.27.
Builders FirstSource’s stock price is averaging around $12. However, the company’s revenue is at its highest-ever value at $3.6 billion.
GuruFocus has found three severe warning signs for Builders Firstsource:
- Beneish M-Score- Possible manipulator of its financial results.
- Sloan Ratio- Poor quality of earnings.
- Faster growth is assets than in revenues.
Builders FirstSource reported its 2016 first-quarter financial results. The company announced net sales of $1.4 billion, an increase from its 2015 first quarter net sales of $1.3 billion and net loss of $17.0 million compared to net loss of $7.1 million in its 2015 first quarter.
President, COO, and CFO M Chad Crow sold 39,467 shares on May 10 at the average price of $11.22. Director Michael Graff, Director David Barr and 10% Owner Pincus Private Equity Warburg sold 39,789,798 shares altogether in May.
Start a free seven-day trial of Premium Membership to GuruFocus.
